27/10/2025
Kidney cancer represents 4% of all new cancer cases in the United States and there has been a consistent increase in its incidence over recent decades, largely attributed to more frequent use of routine imaging studies for unrelated medical reasons.
Read a study in press now with IJPT that suggests proton-based SBRT improved target coverage while reducing the dose to OARs in primary renal cell carcinoma patients: https://www.sciencedirect.com/science/article/pii/S2331518025004755